Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.60 |
| ▸ | CASP2 | P42575 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 3/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4147161 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8210761 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8204892 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL2343012 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL3915907 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL4146733 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL4141617 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL11104897 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8205915 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8198288 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4362886-A1 | SPRAY DEVICES FOR ANTIPERSPIRANT OR DEODORANT COMPOSITIONS WITH A COMPRESSED GAS PROPELLANT | The Procter & Gamble Company (US) | 2024-05-08 | — | — | EP | claimed |
| US-20230015204-A1 | SPRAY DEVICES FOR ANTIPERSPIRANT OR DEODORANT COMPOSITIONS WITH A COMPRESSED GAS PROPELLANT | THE PROCTER & GAMBLE COMPANY | 2023-01-19 | — | — | US | claimed |
| WO-2023278505-A1 | SPRAY DEVICES FOR ANTIPERSPIRANT OR DEODORANT COMPOSITIONS WITH A COMPRESSED GAS PROPELLANT | THE PROCTER & GAMBLE COMPANY (US) | 2023-01-05 | — | — | WO | claimed |
| EP-3021824-B2 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2022-04-13 | — | — | EP | claimed |
| EP-3960149-A1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | The Procter & Gamble Company (US) | 2022-03-02 | — | — | EP | claimed |
| EP-3021819-B1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2021-11-24 | — | — | EP | claimed |
| EP-3021821-B2 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2020-11-04 | — | — | EP | claimed |
| EP-3021823-B1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2018-08-22 | — | — | EP | claimed |
| EP-3021820-B1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2018-08-22 | — | — | EP | claimed |
| EP-3021824-B1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2018-04-11 | — | — | EP | claimed |
| EP-3021825-B1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2018-04-11 | — | — | EP | claimed |
| EP-3021821-B1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-29 | — | — | EP | claimed |
| EP-3021822-B1 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-08-30 | — | — | EP | claimed |
| US-20260092453-A1 | PROTECTED BUILDING PANEL | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12460099-B2 | Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment | THE PILOT INK CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| US-4587537-A | WAX, A TEREPHTHALATE, BENZYL P-HYDROXYBENZOATE DEVELOPER | MITSUBISHI PAPER MILLS, LTD. (JP) | 1986-05-06 | — | — | US | disclosed |
| EP-0018039-B1 | FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1984-03-07 | — | — | EP | disclosed |
| US-4425161-A | Thermochromic materials | PILOT INK COMPANY, LTD., (JP) | 1984-01-10 | — | — | US | disclosed |
| US-4353834-A | Carbonate and carboxylic acid ester group-containing non-ionic surface-active agents | BASF WYANDOTTE CORPORATION (US) | 1982-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | TYR, SCO2, HBB | FAAH 4333/4885HSP90AA1 1824/4885DNM1 4215/4885 |
| US-20260092453-A1 | PROTECTED BUILDING PANEL | DSP, PEBP1, CDH1 | FAAH 1400/4885HSP90AA1 1860/4885DNM1 4161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.